- TWD2.19bn
- TWD1.14bn
- TWD1.23bn
- 40
- 45
- 51
- 39
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 867 | 804 | 1,222 | 1,356 | 1,231 |
Cost of Revenue | |||||
Gross Profit | 140 | 79.3 | 169 | 226 | 223 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 911 | 901 | 1,220 | 1,323 | 1,204 |
Operating Profit | -43.9 | -97.4 | 2.32 | 32.8 | 27 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -3.44 | -89 | -0.816 | 63.4 | 131 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.8 | -87.9 | -3.4 | 43.3 | 106 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -19.6 | -92.4 | -12.2 | 31 | 94.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -19.6 | -92.4 | -12.2 | 31 | 94.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.245 | -1.15 | -0.147 | 0.387 | 1.18 |
Dividends per Share |